Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
Open Access
- 14 December 2009
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 187 (6), 859-874
- https://doi.org/10.1083/jcb.200903131
Abstract
Mammalian target of rapamycin (mTOR) is a key regulator of cell growth that associates with raptor and rictor to form the mTOR complex 1 (mTORC1) and mTORC2, respectively. Raptor is required for oxidative muscle integrity, whereas rictor is dispensable. In this study, we show that muscle-specific inactivation of mTOR leads to severe myopathy, resulting in premature death. mTOR-deficient muscles display metabolic changes similar to those observed in muscles lacking raptor, including impaired oxidative metabolism, altered mitochondrial regulation, and glycogen accumulation associated with protein kinase B/Akt hyperactivation. In addition, mTOR-deficient muscles exhibit increased basal glucose uptake, whereas whole body glucose homeostasis is essentially maintained. Importantly, loss of mTOR exacerbates the myopathic features in both slow oxidative and fast glycolytic muscles. Moreover, mTOR but not raptor and rictor deficiency leads to reduced muscle dystrophin content. We provide evidence that mTOR controls dystrophin transcription in a cell-autonomous, rapamycin-resistant, and kinase-independent manner. Collectively, our results demonstrate that mTOR acts mainly via mTORC1, whereas regulation of dystrophin is raptor and rictor independent.Keywords
This publication has 51 references indexed in Scilit:
- An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1Journal of Biological Chemistry, 2009
- The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by Insulin Largely in a Raptor- or Rictor-Independent MannerMolecular and Cellular Biology, 2009
- Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle DystrophyCell Metabolism, 2008
- Myogenic Akt signaling upregulates the utrophin–glycoprotein complex and promotes sarcolemma stability in muscular dystrophyHuman Molecular Genetics, 2008
- Muscle-Specific Deletion of Rictor Impairs Insulin-Stimulated Glucose Transport and Enhances Basal Glycogen Synthase ActivityMolecular and Cellular Biology, 2008
- Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathwayExperimental Cell Research, 2006
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature, 2004
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent MechanismOnline Journal of Public Health Informatics, 2001
- Increased Number of Caveolae and Caveolin-3 Overexpression in Duchenne Muscular DystrophyBiochemical and Biophysical Research Communications, 1999